With the super-contagious omicron variants getting better at dodging protection, the FDA decided boosters needed an update.
They found adding the extra protection was safe — and spurred production of more omicron-fighting antibodies than just getting another dose of today’s vaccine.
“We’re continuing to collect more data from our study on BA.4/5 and will be in touch as soon as we are ready to submit,” Pfizer spokeswoman Jerica Pitts said in an emailed message.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Tweaked COVID boosters in US must target newer omicron typesU.S. regulators are telling COVID-19 vaccine makers to tweak any booster doses intended for fall so they protect against the newest omicron relatives
Read more »
Pfizer signs new $3.2 billion COVID vaccine deal with U.S. governmentPfizer Inc and partner BioNTech SE said on Wednesday they signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine, which could be delivered as soon as later this summer.
Read more »
Pfizer Seeks FDA’s Full Approval for Paxlovid Covid-19 PillApproval of Paxlovid, which has been available under an Food and Drug Administration authorization for use during the pandemic, would allow Pfizer to market and sell it commercially.
Read more »
U.S. FDA will decide on redesigned COVID vaccines by early JulyU.S. regulators plan to decide by early July whether to change the design of COVID-19 vaccines this fall in order to combat more recent variants of the coronavirus, with hopes of launching a booster campaign by October, a top Food and Drug Administration official said on Tuesday.
Read more »
U.S. Supply of Effective Covid Antibody Drug DwindlingThe last doses of the drug, one of a few found to reduce the risk of severe disease even after Omicron, will be used up in late August unless Congress approves more pandemic funding, administration officials say.
Read more »